Characterization of toxicokinetics and toxicodynamics with linear systems theory: application to lead-associated cognitive decline.
暂无分享,去创建一个
B S Schwartz | J M Links | K Bandeen-Roche | D Simon | W F Stewart | J. Links | W. Stewart | B. Schwartz | K. Bandeen-Roche | D. Simon
[1] U. Scheffel,et al. Regional distribution of 203PbCl2 in the mouse after intravenous injection. , 1998, Neurotoxicology.
[2] Walter F. Stewart,et al. Different Associations of Blood Lead, Meso 2,3-Dimercaptosuccinic Acid (DMSA)-Chelatable Lead, and Tibial Lead Levels with Blood Pressure in 543 Former Organolead Manufacturing Workers , 2000, Archives of environmental health.
[3] B S Schwartz,et al. Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. , 1999, Occupational and environmental medicine.
[4] Howard Hu,et al. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.
[5] B. Gordon,et al. Past adult lead exposure is associated with longitudinal decline in cognitive function , 2000, Neurology.
[6] D. Cory-Slechta,et al. Homogeneity of regional brain lead concentrations. , 1994, Neurotoxicology.
[7] Howard Hu,et al. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. , 1991, American journal of industrial medicine.
[8] Howard Hu,et al. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. , 1989, Environmental research.
[9] W. Trethowan,et al. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. , 1988, British journal of industrial medicine.
[10] T. Smith,et al. Pharmacokinetic models in the development of exposure indicators in epidemiology. , 1991, The Annals of occupational hygiene.
[11] S. Zeger,et al. Modelling disease progression in terms of exposure history. , 1999, Statistics in medicine.
[12] D Simon,et al. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers , 1999, Neurology.
[13] J O Christoffersson,et al. Kinetics of lead in bone and blood after end of occupational exposure. , 1991, Pharmacology & toxicology.
[14] J M Links,et al. Biomarkers and mechanistic approaches in environmental epidemiology. , 1995, Annual review of public health.
[15] D R Smith,et al. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure. , 1999, Toxicology and applied pharmacology.
[16] H Kromhout,et al. Assessment of long-term exposures to toxic substances in air. , 1991, The Annals of occupational hygiene.
[17] A. W. M. van den Enden,et al. Discrete Time Signal Processing , 1989 .
[18] C E Webber,et al. Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. , 1998, Environmental research.
[19] A C Todd,et al. In vivo X-ray fluorescence of lead in bone: review and current issues. , 1994, Environmental health perspectives.
[20] D Simon,et al. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. , 2000, Environmental health perspectives.
[21] E J O'Flaherty,et al. Evaluation and modification of a physiologically based model of lead kinetics using data from a sequential isotope study in cynomolgus monkeys. , 1998, Toxicology and applied pharmacology.
[22] R Attewell,et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. , 1993, Archives of environmental health.